Agenda.
- Agenda -
Thursday 10th April 2025
1200-1245
Arrival Lunch & Registration
1245-1250
Welcome Address
Mr Hubert Gallagher – Irish Society Of Urology
Chairs:
Ms Aisling Looney, St Vincent’s University Hospital & Dr Patricia Daly, St James’s Hospital
1300 - 1320
Local Therapy With Node Positive Or Overt Metastatic Prostate Cancer
Dr Brian Chapin
MD Anderson Cancer Center
1320 - 1340
Novel Bladder-Preserving Approaches for Muscle-Invasive Bladder Cancer
Dr Kent Mouw
Dana Farber Cancer Institute
1340 - 1400
Exploring Novel Approaches to Advance Prostate Cancer Care
Dr Diogo Bastos
Hospital Sirio Libanes, Sao Paulo
1400 - 1420
Survivorship
Prof. David Ralph
University College Hospital London
1420 - 1510
Panel Discussion - PROSTATE
1515 - 1545
Coffee Break
Chairs:
Dr Arun Thomas, Beacon Hospital & Dr Richard O’Dwyer, Mater Misericordiae University Hospital
1545 - 1605
Understanding & Targeting IRE1 in Cancer
Dr Claire Robinson
University College Dublin
1605 – 1625
Lymph node dissection during radical cystectomy for bladder cancer- where do we stand?
Prof Sia Daneshmand
University of Southern California
1625 - 1645
Novel Treatments in Bladder Cancer
Dr Kala Sridhar
Princess Margaret Cancer Center
1645 - 1705
Evaluating & Optimizing Treatment Candidacy With Personalized Prehabilitation
Dr Sarah Psutka
University of Washington
1705 - 1725
Prostate SBRT: Keeping the PACE
Prof Nicholas van As
The Royal Marsden
1725 - 1745
Understanding The Nuances Of And Treating Intermediate-Risk Non-Muscle Invasive Bladder Cancer
Dr Ashish Kamat
MD Anderson Cancer Center
1745 - 1805
Things I Wish I Had Known 25 Years Ago
Prof Roger Kirby
President of the Royal Society of Medicine
1800-1815
Closing Remarks and End of Day 1
Friday 11th April 2025
0825-0830
Opening Remarks Day 2
Chairs:
Chairs: Mr Kevin O’Connor, Cork University Hospital & Dr Ronan McDermott, University Hospital Galway
0830 - 0850
Novel Diagnostic Methods for Detecting Prostate Cancer
Prof Alan McNeill
Western General, Edinburgh
0850 - 0910
Contemporary Trimodality Therapy (TMT) for Muscle-Invasive Bladder Cancer
Dr Kent Mouw
Dana Farber Cancer Institute
0910 - 0930
Pathology
Prof Arndt Hartmann
University Erlangen- Nurnberg
0930 - 0950
Novel & Emerging Therapeutic Strategies for Prostate Cancer
Dr Richard Bambury
Cork University Hospital
0950 - 1045
Bladder
Panel Discussion
1045 - 1115
Coffee Break
Chairs:
Chairs: Ms Beth Hickerton, Cork University Hospital & Dr Orla Houlihan, Cork University Hospital
1115 - 1135
The Patient Journey
Patient Advocate
1135 - 1155
RPLND for Stage II Germ Cell tumors. New Standard?
Prof Sia Daneshmand
University of Southern California
1155 - 1215
Prostate & Translational Research
Simon McDade
Queen’s University Belfast
1215 - 1235
Bladder Cancer Updates
Dr Kala Sridhar
Princess Margaret Cancer Center
1235 - 1255
SBRT for High-Risk Patients: Tailoring Treatment
Prof Nicholas van As
The Royal Marsden
1255 - 1315
Biochemical Relapse Of Prostate Cancer After Primary Local Therapy
Dr Brian Chapin
MD Anderson Cancer Center
1315 - 1400
Lunch
Chairs:
Chairs: Ms Catherine Dowling, University Hospital Galway & Dr Lore Komanyane, Sligo University Hospital
1400 - 1420
The Neoplastic Consequences Of Urine On Intestine
Prof Christopher Woodhouse
University College London
1420 - 1440
BCG- Unresponsive Disease: How We Got Here And Where We’re Heading
Dr Ashish Kamat
MD Anderson Cancer Center
1440 - 1500
Cancer Care in Brazil
Dr Diogo Bastos
Hospital Sirio Libanes, Sao Paulo
1500 - 1520
Integrative Medicine Strategies To Reduce Urologic Treatment Toxicity
Dr Sarah Psutka
University of Washington
1520 - 1615
Panel Discussion - Kidney
1615
End of Proceedings